封面
市场调查报告书
商品编码
1728035

全球心内膜切片检查市场:市场规模、份额、趋势分析(按产品、晶片、最终用途和地区)、细分市场预测(2025-2030 年)

Endomyocardial Biopsy Market Size, Share & Trends Analysis Report By Product (Forceps, Accessories), By Tip (Straight, Pre-curved), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

心内膜切片检查市场的成长与趋势:

根据 Grand View Research, Inc 的最新报告,全球心内膜切片检查市场预计到 2030 年将达到 5.43 亿美元,2025 年至 2030 年的复合年增长率为 6.9%。

市场的成长归因于心血管疾病(CVD)盛行率的上升、对微创手术的需求不断增长以及冠状动脉介入手术的优惠报销政策等因素。

技术进步和跨国公司在新兴国家的投资增加为市场成长和扩张提供了理想的机会。在新兴国家,医疗改革趋势正在显现,医疗产品和医疗设备技术正在不断进步。这为製造商推出了自己的产品并占领了相当一部分市场,创造了机会。印度和中国等发展中国家正在逐步改变其医疗保健系统,为患者提供更好的治疗选择。

此外,已开发国家拥有更好的医疗基础设施,这意味着先进的诊断和治疗方案很容易获得。根据器官共享联合网路发布的数据,2022 年美国进行了超过 4,111 例心臟移植手术。随着心臟移植数量的增加,定期监测和早期发现排斥反应的需求也将增加。这可能会进一步推动对心内膜切片检查的需求。

心内膜切片检查市场:概述

  • 到 2024 年,产钳部分将占据产品领域的主导地位,收入份额最大,为 71.9%,这主要得益于心血管疾病盛行率的上升和医疗技术的进步。
  • 由于心臟手术的增加和对专用工具的需求,预计预测期内配件的复合年增长率将达到 6.3%。
  • 线性部分在全球心内膜切片检查市场占据主导地位,2024 年占据 36.2% 的最大收入份额。这是由于其精确度、易用性、适合常规程序以及直线设计,可实现高效组织收集、缩短手术时间并提高样本可靠性。
  • 由于弯曲尖端具有增强的可操作性和导航复杂心臟解剖结构的能力,预计在预测期内弯曲尖端将以显着的复合年增长率增长。
  • 2024年,医院占据了收益占有率。预计预测期内门诊手术中心 (ASC) 部分的复合年增长率为 6.0%。
  • 2024 年,北美占据全球心内膜切片检查市场的最大收入份额。这是由于先进的医疗基础设施、心血管疾病盛行率的上升、心臟移植手术数量的增加以及对早期疾病诊断认识的提高。
  • 预计 2025 年至 2030 年期间亚太市场将以最快的复合年增长率成长。这是由于老年人口的增长、心臟疾病率的上升、医疗保健服务的改善以及政府的倡议。

目录

第一章 分析方法与范围

第二章执行摘要

3. 心内膜切片检查市场:驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 心内膜切片检查市场:分析工具
    • 产业分析:波特五力分析
    • PESTEL分析

第四章全球心内膜切片检查市场:按产品分類的业务分析

  • 产品仪表板
  • 心内膜切片检查市场:依产品进行趋势分析
  • 全球心内膜切片检查市场规模及产品趋势分析(2018-2030)
  • 钳子
  • 配件

5. 全球心内膜切片检查市场:晶片业务分析

  • 晶片专用仪表板
  • 心内膜切片检查市场:晶片趋势分析
  • 全球心内膜切片检查市场规模及晶片趋势分析(2018-2030)
  • 活动
  • 线性
  • 弯曲
  • 其他的

6. 全球心内膜切片检查市场:依最终用途分類的业务分析

  • 最终用途仪表板
  • 心内膜切片检查市场:依最终用途进行趋势分析
  • 全球心内膜切片检查市场规模及趋势分析(依最终用途)(2018-2030)
  • 医院
  • 门诊手术中心
  • 其他的

7. 全球心内膜切片检查市场:按地区估计与趋势分析

  • 市场仪表板:按地区
  • 各地区市场占有率分析(2024 年及 2030 年)
  • 全球心内膜切片检查市场:按地区分類的关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析(2024年)
  • 公司简介
    • Argon Medica Devices, Inc.
    • Cordis
    • Mermaid Medical
    • Terumo Corporation
    • Scholten Surgical Instruments, Inc.
    • Changzhou Lookmed Medical Instrument Co., Ltd.
    • Fehling Instruments
Product Code: GVR-4-68040-064-6

Endomyocardial Biopsy Market Growth & Trends:

The global endomyocardial biopsy market is anticipated to reach USD 543.0 million by 2030 and is anticipated to expand at a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors such as increasing prevalence of Cardiovascular Disorders (CVDs), rising demand for minimally invasive surgical procedures, and favorable reimbursement policies for coronary intervention procedures.

An increase in technological advancements and investment of multinational companies in emerging economies serve as ideal opportunities for the growth and expansion of a market. There is a trend of healthcare reforms and advancements in technology for medical products and devices in emerging economies. This creates an opportunity for manufacturers to introduce their products and capture a significant portion of the market. Countries like India, China, and others are developing and are bringing about incremental changes to their healthcare systems, providing enhanced treatment options to patients.

Furthermore, the well-established healthcare infrastructure in developed countries enables easy accessibility to advanced diagnostic and treatment options. According to data published by the United Network for Organ Sharing, in 2022, over 4,111 heart transplants were performed in the U.S. As the number of heart transplants increases, the need for regular monitoring and early detection of rejection would also increase. This would further boost the demand for endomyocardial biopsy procedures.

Endomyocardial Biopsy Market Report Highlights:

  • The forceps segment dominated the product segment with the largest revenue share of 71.9% in 2024, primarily driven by the growing prevalence of cardiovascular diseases and advancements in medical technology.
  • Accessories are expected to grow at a lucrative CAGR of 6.3% growth over the forecast period, owing to the rising number of cardiac procedures and the need for specialized tools.
  • The straight tip segment dominated the global endomyocardial biopsy market and held the largest revenue share of 36.2% in 2024, attributed to their precision, ease of use, and suitability for routine procedures as well as their straightforward design, which allows for efficient tissue collection, reducing procedure time and enhancing sample reliability.
  • Pre-curved tips are expected to grow at a significant CAGR over the forecast period, driven by their enhanced maneuverability and capability to navigate complex cardiac anatomy.
  • Hospital held the largest revenue share in 2024. The ambulatory surgery center (ASC) segment is anticipated to grow at a CAGR of 6.0% over the forecast period.
  • North America dominated the global endomyocardial biopsy market with the largest revenue share in 2024, driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, rising heart transplant procedures, and growing awareness of early disease diagnosis.
  • Asia Pacific market is projected to grow at the fastest CAGR from 2025 to 2030, attributed to a rising geriatric population, increasing occurrence of cardiac disorders, improving healthcare access, and government initiatives.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Tip
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Tip Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Endomyocardial Biopsy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Endomyocardial Biopsy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Endomyocardial Biopsy Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Endomyocardial Biopsy Market: Product Movement Analysis
  • 4.3. Global Endomyocardial Biopsy Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Forceps
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Accessories
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Endomyocardial Biopsy Market: Tip Business Analysis

  • 5.1. Tip Segment Dashboard
  • 5.2. Endomyocardial Biopsy Market: Tip Movement Analysis
  • 5.3. Global Endomyocardial Biopsy Market Size & Trend Analysis, By Tip, 2018 to 2030 (USD Million)
  • 5.4. Maxi-curved
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Straight
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Pre-curved
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Endomyocardial Biopsy Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Endomyocardial Biopsy Market: End Use Movement Analysis
  • 6.3. Global Endomyocardial Biopsy Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Endomyocardial Biopsy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Endomyocardial Biopsy Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Argon Medica Devices, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Cordis
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Mermaid Medical
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Terumo Corporation
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Scholten Surgical Instruments, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Changzhou Lookmed Medical Instrument Co., Ltd.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Fehling Instruments
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 3. Global Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 4. Global Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5. Global Eye Health Supplements Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. North America Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 9. North America Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10. U.S. Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 11. U.S. Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 12. U.S. Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Canada Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 14. Canada Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 15. Canada Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. Mexico Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Mexico Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 18. Mexico Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19. Europe Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
  • Table 20. Europe Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 21. Europe Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 22. Europe Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23. Germany Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. Germany Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 25. Germany Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. UK Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 27. UK Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 28. UK Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29. France Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. France Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 31. France Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Italy Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 33. Italy Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 34. Italy Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Spain Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 36. Spain Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 37. Spain Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38. Denmark Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 39. Denmark Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 40. Denmark Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Sweden Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 42. Sweden Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 43. Sweden Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44. Norway Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 45. Norway Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 46. Norway Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51. China Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 52. China Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 53. China Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Japan Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 55. Japan Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 56. Japan Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57. India Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 58. India Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 59. India Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 61. South Korea Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 62. South Korea Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. Australia Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 64. Australia Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 65. Australia Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66. Thailand Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 67. Thailand Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 68. Thailand Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69. Latin America Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
  • Table 70. Latin America Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 71. Latin America Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 72. Latin America Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73. Brazil Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 74. Brazil Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 75. Argentina Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 76. Argentina Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 77. Argentina Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78. MEA Eye Health Supplements Market, By Region, 2018 - 2030 (USD Million)
  • Table 79. MEA Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 80. MEA Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 81. MEA Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82. South Africa Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 83. South Africa Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 84. South Africa Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88. UAE Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 89. UAE Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 90. UAE Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91. Kuwait Eye Health Supplements Market, By Product, 2018 - 2030 (USD Million)
  • Table 92. Kuwait Eye Health Supplements Market, By Tip, 2018 - 2030 (USD Million)
  • Table 93. Eye Health Supplements Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Eye Health Supplements Market: Market Outlook
  • Fig. 10 Eye Health Supplements Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Eye Health Supplements Market Driver Impact
  • Fig. 16 Eye Health Supplements Market Restraint Impact
  • Fig. 17 Eye Health Supplements Market Strategic Initiatives Analysis
  • Fig. 18 Eye Health Supplements Market: Product Movement Analysis
  • Fig. 19 Eye Health Supplements Market: Product Outlook and Key Takeaways
  • Fig. 20 Forceps Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Accessories Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Eye Health Supplements Market: Tip Movement Analysis
  • Fig. 23 Eye Health Supplements Market: Tip Outlook and Key Takeaways
  • Fig. 24 Maxi-curved Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 Straight Market Estimates and Forecasts, 2018 - 2030
  • Fig. 26 Pre-curved Market Estimates and Forecasts, 2018 - 2030
  • Fig. 27 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 Eye Health Supplements Market: End Use Movement Analysis
  • Fig. 29 Eye Health Supplements Market: End Use Outlook and Key Takeaways
  • Fig. 30 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 31 Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Global Eye Health Supplements Market: Regional Movement Analysis
  • Fig. 34 Global Eye Health Supplements Market: Regional Outlook and Key Takeaways
  • Fig. 35 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Kuwait Market Estimates and Forecasts, 2018 - 2030